Barry Goldberg
Internal Medicine · Highland Park, ILNPI 1760450548
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 237 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,425 and has fallen 94.8% since, to $74 in 2022. Among internal medicine clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 237 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$710
- Amarin Pharma, Inc.$400
- Amgen$344
- GSK$242
- IBSA Pharma Inc.$222
- Johnson & Johnson$217
- plus $2K from 22 others
What the payments were for
- Food & beverage$3,66197%
- Education$953%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 68 | $710 |
| Amarin Pharma, Inc. | 24 | $400 |
| Amgen(2 entities) | 19 | $344 |
| GSK | 13 | $242 |
| IBSA Pharma Inc. | 12 | $222 |
| Johnson & Johnson | 11 | $217 |
| Astellas Pharma US Inc | 6 | $189 |
| Boehringer Ingelheim | 9 | $161 |
| Pfizer | 8 | $154 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $138 |
| AstraZeneca | 8 | $136 |
| E.r. Squibb & Sons, L.L.C. | 7 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $105 |
| Biohaven Pharmaceuticals, Inc. | 4 | $87 |
| Novo Nordisk | 4 | $85 |
| Kowa Pharmaceuticals America, Inc. | 4 | $71 |
| Genentech USA, Inc. | 3 | $57 |
| Bausch Health US, LLC | 3 | $56 |
| Lilly USA, LLC | 3 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Novartis | 2 | $29 |
| Sunovion Pharmaceuticals Inc. | 2 | $28 |
| Medicure Pharma Inc. | 2 | $27 |
| Dentsply Sirona Inc | 1 | $20 |
| Metuchen Pharmaceuticals | 1 | $18 |
| Shire North American Group Inc | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
How this compares
$3,756 in reported general payments places this provider in the 90th percentile of 5,182 internal medicine providers in Illinois.
Other internal medicine in Highland Park
- Zaid JabbarOak Brook$1.2M
- Merle DiamondChicago$1.1M
- David ReckerLibertyville$868K
- Yazen JoudehOrland Park$661K
- Robert KushnerChicago$516K
- William CruikshankOak Lawn$431K
- Romeo UrsuaChicago$420K
- Shaina RozellChicago Ridge$366K
- Kristi Tough DesapriWinnetka$344K
- Peter O DonnellChicago$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.